Table 2.10Longitudinal studies on the association of smoking with cough, bronchitis symptoms, shortness of breath, wheeze, and asthma in cohorts followed since childhood

StudyPopulationPeriod of studyFindingsDefinitions/comments
Strachan et al. 1996; Butland and Strachan 200718,550 people born March 3–9, 1958, in England, Scotland, or Wales 5,801 contributed information at 7, 11, 16, 23, and 33 years of age1958–1991
  • Active cigarette smoking was associated with incidence of asthma or wheezing illness from 17 to 33 years of age (OR = 4.42; 95% CI, 3.31–5.92)
  • Relapse after prolonged remission of childhood wheezing was more common among current smokers
  • At 42–45 years of age, the proportions of incident asthma and incident wheeze without asthma associated with cigarette smoking were estimated to be 13% (95% CI, 0–26) and 34% (95% CI, 27–40)
Attrition bias was evaluated using information on 14,571 subjects
Bodner et al. 1998Study of subjects aged 39–45 years derived from an Aberdeen cohort of 2,056 asymptomatic children originally studied in 1964 117 cases with adult-onset wheeze 277 controls1964–1995
  • Current smoking was associated with increased risk of adult-onset wheeze (RR = 2.01; 95% CI, 1.08–3.74)
Case-control study nested in longitudinal follow-up study
Withers et al. 19982,289 children
Baseline: 6–8 years of age
Follow-up: 14–16 years of age
Southampton, United Kingdom
Baseline: 1978–1980
Follow-up: 1987–1995
  • Regular smoking of at least 1 cigarette/week during past 12 months was associated with:

    Current cough (OR = 1.71; 95% CI, 1.21–2.43)

    Onset of cough between surveys (OR = 4.35; 95% CI, 1.12–3.35)

    Persistent wheeze in boys (OR = 4.35; 95% CI = 1.20–3.25)

    New report of wheezing (OR = 1.65; 95% CI, 1.14–2.39)

  • Regular smoking was not associated with physician-diagnosed asthma
Dose-response relationships observed
Sears et al. 20031,037 children
Birth cohort followed repeatedly from 9–26 years of age
New Zealand
Baseline: 1972–1973
  • Smoking at 21 years of age predicted persistence of wheeze from the study onset (adjusted OR = 1.84; 95% CI, 1.13–3.00).
  • Relapse of wheezing at 26 years of age after being wheeze free was significantly associated with smoking at 21 years of age in a univariate model (OR = 1.84; 95% CI, 1.11–3.04), but multivariate model controlling for bronchial hyperresponsiveness was not significant for relapse
Case-control study nested in longitudinal follow-up study
Genuneit et al. 2006; Vogelberg et al. 20072,936 children
Dresden and Munich, Germany
Baseline: 1995–1996
Follow-up: 2002–2003
  • For those with no respiratory symptoms at baseline, current smoking predicted development of wheeze at follow-up (OR = 2.8; 95% CI, 1.6–4.9 for girls; OR = 1.8; 95% CI, 0.9–3.9 for boys)
Gilliland et al. 20062,609 children with no lifetime history of asthma or wheezing
Baseline: 4th to 7th grades California
1993–2003
  • Smoking 300 or more cigarettes/year was associated with increased risk of new-onset asthma (RR = 3.9; 95% CI, 1.7–8.5)
Goksör et al. 200689 of 101 children hospitalized before the age of 2 years with wheezing
Follow-up until 17–20 years of age
Baseline: 1984–1985
  • Active smoking was associated with increased odds of current asthma (OR = 3.2; 95% CI, 1.2–8.4)
Tollefsen et al. 20072,300 adolescents
Baseline: 13–15 years of age
Follow-up: 17–19 years of age
Baseline: 1995–1997
Follow-up: 2000–2001
  • For those with no respiratory symptoms at baseline, current smoking predicted development of wheeze at follow-up, which was significant for girls (OR = 2.8; 95% CI, 1.6–4.9 for girls; OR = 1.8; 95% CI, 0.9–3.9 for boys)

Note: CI = confidence interval; OR = odds ratio; RR = relative risk.

From: 2, The Health Consequences of Tobacco Use Among Young People

Cover of Preventing Tobacco Use Among Youth and Young Adults
Preventing Tobacco Use Among Youth and Young Adults: A Report of the Surgeon General.
National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.